New Data Reinforces Potential Of Sanofi's Sutimlimab After Shock FDA Snub

Second Positive Phase III Trial In Cold Agglutinin Disease

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.